ACM
JNJ icon

Avos Capital Management’s Johnson & Johnson JNJ Stock Holding History

Avos Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,919
Closed -$397K – 55
2025
Q4 		$397K Hold
1,919
– – 0.17% 45
2025
Q3 		$356K Buy
+1,919
New +$329K 0.17% 44

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avos Capital Management's JNJ Position: Q1 2026 in Review

Avos Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,919 shares — an estimated $397K sold.

Avos Capital Management first reported a position in JNJ in Q3 2025 and held it in 2 quarters. The position peaked at $397K in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Avos Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Avos Capital Management sold 1,919 Johnson & Johnson shares in Q1 2026, an estimated $397K.
  • Avos Capital Management first reported a position in Johnson & Johnson in Q3 2025 and held it in 2 quarters.
  • Avos Capital Management's Johnson & Johnson position peaked at $397K in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Avos Capital Management's 13F filing for Q1 2026, filed 15 May 2026.